New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today (June 30) in Nature Microbiology, reveals an opportunity for developing a therapy against cytomegalovirus (CMV), the leading…
New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today (June 30) in Nature Microbiology, reveals an opportunity for developing a therapy against cytomegalovirus (CMV), the leading…